3-Bromobenzyl bromide, 99%, Thermo Scientific Chemicals
3-Bromobenzyl bromide, 99%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

3-Bromobenzyl bromide, 99%, Thermo Scientific Chemicals

Have Questions?
Change viewbuttonViewtableView
Quantity:
250 g
10 g
50 g
Catalog number A15075.30
also known as A15075-30
Price (USD)/ Each
922.00
-
Add to cart
Quantity:
250 g
Request bulk or custom format
Price (USD)/ Each
922.00
Add to cart
3-Bromobenzyl bromide, 99%, Thermo Scientific Chemicals
Catalog numberA15075.30
Price (USD)/ Each
922.00
-
Add to cart
Chemical Identifiers
CAS823-78-9
IUPAC Name1-bromo-3-(bromomethyl)benzene
Molecular FormulaC7H6Br2
InChI KeyZPCJPJQUVRIILS-UHFFFAOYSA-N
SMILESBrCC1=CC=CC(Br)=C1
View more
SpecificationsSpecification SheetSpecification Sheet
Appearance (Color)White
Assay (GC)≥98.5%
Melting Point (clear melt)38.0-45.0?C
FormCrystals or powder or crystalline powder or lumps or fused solid
3-Bromobenzyl bromide was used in the synthesis of, 1,7-di(3-bromobenzyl)cyclen and substituted 8-arylquinoline, phosphodiesterase 4 (PDE4) inhibitors.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
3-Bromobenzyl bromide was used in the synthesis of, 1,7-di(3-bromobenzyl)cyclen and substituted 8-arylquinoline, phosphodiesterase 4 (PDE4) inhibitors.

Solubility
Insoluble in water.

Notes
Store in cool, dry place in tightly closed container. Store away from oxidizing agent.
RUO – Research Use Only

General References:

  1. Averin AD, et al. Synthesis of a new family of bi-and polycyclic compounds via Pd-catalyzed amination of 1, 7-di (3-bromobenzyl) cyclen. Tetrahedron Lett, 2008, 49(24), 3950-54.
  2. Dwight Macdonald et. al. Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor. Bioorganic & Medicinal Chemistry Letters, 2005, 15(23), 5241-5246.